Cbdmd continues to drive operational improvement

Repositions product portfolio with effective, industry leading concentrations now supported by clinical claimscharlotte, north carolina--(newsfile corp. - december 15, 2022) - cbdmd, inc. (nyse american: ycbd) (nyse american: ycbdpa), one of the nation's leading and most highly trusted and recognized cbd companies, and operator of three of the leading cbd brands -- its flagship brand cbdmd, its animal health brand paw cbd, today announced our quarterly and full fiscal financial results for september 30, 2022. while we incurred a gaap loss from operations of $78.
YCBD Ratings Summary
YCBD Quant Ranking